Search Results - "Kirkman, R L"

Transmission of Hepatitis C Virus by Organ Transplantation by Pereira, Brian J.G, Milford, Edgar L, Kirkman, Robert L, Levey, Andrew S

“…LIVER disease is an important cause of morbidity J and mortality in renal-transplant recipients, with abnormalities of liver function occurring in 7 to 24…”
Get full text

Prevalence of Hepatitis C Virus RNA in Organ Donors Positive for Hepatitis C Antibody and in the Recipients of Their Organs by Pereira, Brian J.G, Milford, Edgar L, Kirkman, Robert L, Quan, Stella, Sayre, Keith R, Johnson, Pamela J, Wilber, Judith C, Levey, Andrew S

“…VIRUSES are an important cause of liver disease in organ-transplant recipients. 1 , 2 The cloning of the genome for hepatitis C virus (HCV), the principal…”
Get full text

Vascular access for hemodialysis: patency rates and results of revision by PALDER, S. B, KIRKMAN, R. L, WHITTEMORE, A. D, HAKIM, R. M, LAZARUS, J. M, TILNEY, N. L

“…Over a 4-year interval, 324 arteriovenous conduits were created in 256 patients with end-stage renal disease as access for chronic hemodialysis. These included…”
Get full text

New usage paradigms in antibody therapy: induction or true prophylaxis? by Kirkman, R.L

Get full text

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation by Kirkman, R L, Shapiro, M E, Carpenter, C B, McKay, D B, Milford, E L, Ramos, E L, Tilney, N L, Waldmann, T A, Zimmerman, C E, Strom, T B

“…Patient entry is now complete in a prospective trial of anti-Tac, a murine IgG2a monoclonal antibody directed against the p55 chain of the human IL-2 receptor,…”
Get more information

Liver disease in recipients of long-functioning renal allografts by WEIR, M. R, KIRKMAN, R. L, STROM, T. B, TILNEY, N. L

“…After noting that hepatic failure was the leading cause of death in our transplant recipients whose renal allografts had functioned for more than five years,…”
Get full text

Small bowel transplantation by Kirkman, R L

Get more information

Cardiac Allograft Survival in Mice Treated with IL-2-PE40 by Lorberboum-Galski, Haya, Barrett, Leslie V., Kirkman, Robert L., Ogata, Masato, Willingham, Mark C., FitzGerald, David J., Pastan, Ira

“…IL-2-PE40 is a chimeric protein composed of human interleukin 2 (IL-2) genetically fused to the amino terminus of a modified form of Pseudomonas exotoxin…”
Get full text

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice by KIRKMAN, R. L, BARRETT, L. V, GAULTON, G. N, KELLEY, V. E, YTHIER, A, STROM, T. B

“…Administration of the monoclonal antibody M7/20, which binds to the murine interleukin-2 (IL) receptor, significantly prolongs cardiac allograft survival in…”
Get full text

Small intestine transplantation in the rat--immunology and function by Kirkman, R L, Lear, P A, Madara, J L, Tilney, N L

“…Heterotopic, vascularized small intestine transplants were performed in inbred strains of rats to investigate the structural, functional, and immunologic…”
Get more information

Structural and functional evolution of jejunal allograft rejection in rats and the ameliorating effects of cyclosporine therapy by MADARA, J. L, KIRKMAN, R. L

“…We assessed the structural and functional evolution of small intestinal transplant rejection in a rat model by use of 1-micron section, electron microscopic,…”
Get full text

Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts by Xia, W, Fearon, D T, Kirkman, R L

Get more information

Phosphorylation of the enantiomers of the carbocyclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase by Bennett, Jr, L L, Parker, W B, Allan, P W, Rose, L M, Shealy, Y F, Secrist, 3rd, J A, Montgomery, J A, Arnett, G, Kirkman, R L, Shannon, W M

“…CdG, the carbocyclic analog of 2'-deoxyguanosine, is active against herpes, hepatitis B, and human cytomegaloviruses. We have studied the interaction of the…”
Get more information

Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site by Han, Wenlong, Wind-Rotolo, Megan, Kirkman, Richard L., Morrow, Casey D.

“…The initiation of HIV-1 reverse transcription occurs at an 18-nucleotide sequence in the viral genome designated as the primer binding site (PBS), which is…”
Get full text

Late mortality and morbidity in recipients of long-term renal allografts by Kirkman, R L, Strom, T B, Weir, M R, Tilney, N L

“…The experience of the Peter Bent Brigham Hospital with 217 renal allografts functioning for more than 5 years is reviewed. Patient and graft survival were…”
Get more information

Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials by Snydman, D R, Werner, B G, Tilney, N L, Kirkman, R L, Milford, E L, Cho, S I, Bush, Jr, H L, Levey, A S, Strom, T B, Carpenter, C B

Get more information

Priming the recipient abrogates the inhibitory effect of cyclosporine on specific sIgA production against cholera toxin in small bowel transplantation by Xia, W, Kirkman, R L

Get more information

Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1 by Xia, W, Fearon, D T, Moore, Jr, F D, Schoen, F J, Ortiz, F, Kirkman, R L

Get more information

Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants by Xia, W, Brandeis, J M, Sayegh, M, Kirkman, R L

Get more information

Experience with cyclosporine and steroids in clinical renal transplantation by TILNEY, N. L, MILFORD, E. L, ARAUJO, J.-L, STROM, T. B, CARPENTIER, C. B, KIRKMAN, R. L

“…We have reviewed the results of patient survival and transplant function of the last 100 recipients of renal allografts treated with cyclosporine (CyA) plus…”
Get full text